Replication of eukaryotic genomes is limited to once per cell cycle, by a two-step mechanism [1, 2] . DNA replication origins are first ''licensed'' during G1 phase by loading of an inactive DNA helicase (Mcm2-7) into pre-replicative complexes (pre-RCs). Initiation then occurs during S phase, triggered by cyclin-dependent kinases (CDKs), which promote recruitment of proteins required for helicase activation and replisome assembly [3, 4] . CDKs and the anaphase promoting complex/cyclosome (APC/C) restrict licensing to G1 phase by directly and indirectly regulating pre-RC components [2], including ORC, Cdc6, Cdt1, and Mcm2-7. Despite the fundamental importance of licensing regulation, the mechanisms by which pre-RC components are regulated differ widely across Eukarya. Here we show that even within the genus Saccharomyces, Cdc6 is regulated differently in different species. We propose that two factors contribute to the rapid evolution of licensing regulation. The first is redundancy: eliminating any single pre-RC-regulatory mechanism has very little affect on viability. The second is interchangeability: we show that regulatory mechanisms can be swapped between pre-RC components without compromising the block to re-replication. These experiments provide a framework for understanding the diversity of licensing regulation in eukaryotes and provide new tools for manipulating the chromosome-replication cycle.
Results and Discussion

Comparison of Cdc6 Regulation in Saccharomyces Species
We began to study licensing-control variation in Saccharomyces species by examining the Cdc6 protein. In S.cerevisiae, active Cdc6 protein is present in cells only during early G1 phase [5] [6] [7] . This is because cyclin-dependent kinases (CDKs) inhibit Cdc6 protein by several mechanisms. First, CDKs regulate Cdc6 stability [6] [7] [8] [9] by direct phosphorylation of Cdc6, targeting it for ubiquitin-mediated proteolysis. From late G1 phase through S phase, Cdc6 is very rapidly degraded, which we have previously termed ''mode 2'' degradation [8, 9] . This rapid proteolysis occurs because CDK phosphorylation generates two separate, functional binding sites for Cdc4, an F box-containing substrate-recognition subunit of the SCF ubiquitin ligase ( Figure S1 , available online). One of these Cdc4 binding sites lies within a 50 amino acid N-terminal regulatory domain (NTD). The second site lies within a C-terminal regulatory domain (CTD) located downstream of the sensor II motif in the AAA+ domain [8, 9] . Cdc6 is also inhibited by direct interaction between the mitotic cyclin Clb2 and the NTD [10, 11] . This binding requires phosphorylation of the NTD and inhibits Cdc6 by preventing it from being recruited to ORC [10] . Clb2 binding also prevents interaction between Cdc6 and Cdc4, which causes partial stabilization of Cdc6 during mitosis [10] . The Cdc4 binding site in the CTD remains accessible during mitosis and is responsible for the slower proteolysis at this time (''mode 3'' degradation). Clb2 in yeast acts analogously to geminin in metazoans: both bind to and inhibit essential licensing factors (Cdc6 and Cdt1, respectively) [1] , both are APC/C substrates [12, 13] , and both stabilize their partners during mitosis by inhibiting ubiquitin-mediated proteolysis [10, 14] .
We examined Cdc6 protein from five Saccharomyces species. Three of these, S.cerevisiae, S.bayanus, and S.kudriavzevii, are closely related (sensu stricto), whereas S.castellii and S.kluyveri are more distantly related (sensu lato) [15, 16] . All five Cdc6 proteins are functional in S.cerevisiae, efficiently complementing a cdc6 temperature-sensitive mutant ( Figure S2A ). Although the AAA+ domain is highly conserved among all of these yeasts, Figure S1B shows that the regulatory domains are not well conserved outside of the sensu stricto yeasts. Within the NTD, all of the Cdc6 proteins contain multiple CDK consensus sites: four in all of the sensu stricto Cdc6 proteins, three in S.castellii Cdc6, and five in S.kluyveri Cdc6. The positions and arrangement of these sites do not appear to be conserved; however, all of the yeasts contain a sequence related to the S.cerevisiae Cdc4 interaction motifs ( S / T PXX S / T PX K / R ) in the NTD [9] . The CDK consensus sites within the CTD are conserved within the sensu stricto Cdc6 proteins but are absent from S.castellii and S.kluyveri Cdc6 proteins.
To determine whether any of these proteins could bind Cdc4, we used a yeast two-hybrid assay. Figure 1A shows that the NTD (see Figure S2B for sequences) from all five yeast Cdc6 proteins interacted with Cdc4, using activation of lacZ and HIS3 reporter genes as readout for interaction. The CTDs from all of the sensu stricto yeast proteins interacted with Cdc4; however, this region from the sensu lato Cdc6 proteins did not interact with Cdc4, consistent with the fact that these proteins lack CDK consensus sites. Figure 1B shows that all five Cdc6 proteins are unstable in nocodazolearrested cells and all five proteins are stabilized after inactivation of Cdc4 with the use of a cdc4 temperature-sensitive mutant. The levels of the sensu lato Cdc6 proteins were lower than those of the sensu stricto proteins after galactose induction, suggesting that they might be more unstable in nocodazole-arrested cells. Next, we examined Cdc6 levels during the cell cycle under conditions in which Cdc6 is transcribed constitutively. To do this, we performed an alpha factor block and release into galactose-containing medium, using strains in which each CDC6 gene was driven by the GAL1,10 promoter. Figure 1C shows that Cdc6 proteins from S.cerevisiae, S.bayanus, and S.castellii all disappear sharply 20-30 min after release, as cells enter S phase. This is consistent with very rapid degradation (mode 2) previously described for S.cerevisiae Cdc6 protein [8] . In both the sensu stricto yeasts (S.cerevisiae and S.bayanus), Cdc6 reaccumulates 70-90 min after release, consistent with the slower mode 3 degradation. In S.castellii, however, Cdc6 levels remain low in G2/M, suggesting that its degradation does not slow significantly after S phase.
The apparent absence of the slower mode 3 degradation in S.castellii Cdc6 suggested that it might not bind to the mitotic cyclin Clb2. Overexpression of the sensu stricto Cdc6 proteins inhibited growth and induced an elongated-bud phenotype consistent with Clb2 inhibition (Figure 2A ). However, overexpression of the two sensu lato Cdc6 proteins had no effect on cell growth or bud morphology, consistent with the possibility that they do not inhibit Clb2. To examine this directly, we performed reciprocal immunoprecipitations of Cdc6 and Clb2 proteins. Figure 2B shows that the sensu stricto Cdc6 proteins all immunoprecipitate efficiently with Clb2, whereas neither of the sensu lato proteins showed efficient Clb2 binding. To examine whether this is because of speciesspecific protein-protein interactions that might be lost in this heterologous system, we expressed the S.castellii Clb2 in the strain expressing the S.castellii Cdc6. Figure 2C shows that no interaction between these proteins was detected in extracts. Thus, in contrast to S.cerevisiae Cdc6, S.castellii Cdc6 does not appear to interact with its cognate Clb2 protein.
Taken together, these experiments indicate that all of the sensu stricto Cdc6 proteins have two Cdc4 binding sites: one in the NTD and one in the CTD. The sensu lato proteins, however, have a Cdc4 binding site only in the NTD. All of the sensu stricto proteins bind Clb2, which appears to stabilize the protein in G2/M, whereas the sensu lato proteins do not bind Clb2. This suggests that the ability of the NTD to bind Clb2 may necessitate the presence of a second Cdc4 targeting sequence. Consistent with this, we have previously shown that in the CTD of Cdc6, a mutation that eliminates Cdc4 interaction is dominant negative [9] . This dominant-negative phenotype is caused by Clb2 binding and can be suppressed by deletion of the NTD. These experiments indicate that the regulation of the Cdc6 protein appears to have diverged within the genus Saccharomyces.
This led us to consider factors that might promote rapid evolution of licensing control. One likely factor is redundancy: CDKs prevent re-replication through multiple mechanisms. Cells expressing Cdc6 lacking the NTD are viable and have apparently normal DNA replication [6] , and strains in which either ORC or Mcm2-7 have been deregulated individually are also viable [17] . Although loss of both ORC and Cdc6 regulation is lethal [10, 18] , strains in which both Cdc6 and Mcm2-7 have been deregulated are viable ( Figure S3A ). Thus, there is considerable functional redundancy in these regulatory mechanisms.
Interchangeable Regulatory Mechanisms
CDKs inhibit pre-RC components by three general mechanisms: targeted proteolysis, nuclear exclusion, and direct binding. A second factor that might contribute to rapid evolution would be the potential for interchangeability; that is, the possibility that in a single organism, re-replication could be prevented by regulation of any pre-RC component by any of (A) Yeast two-hybrid assay used in testing for interaction between Cdc4 and Cdc6 proteins. Two-hybrid constructs containing the putative N terminal (NTD) or C-terminal (CTD) Cdc4 interaction domains of Cdc6 from each yeast species (see Figure S2B ) were assayed for transcriptional activation of the LacZ and the HIS3 genes in the presence of either the empty pAct vector or pAct containing a fragment of Cdc4 fused to the GAL activation domain [6] . Yeast species are termed as follows for brevity: S.cer (S.cerevisiae), S. bay (S.bayanus), S.kud (S.kudriavzevii), S. cas (S.castellii), and S.klu (S.kluyveri). (B) Cdc4-dependent proteolysis. Cells were arrested in G2/M with nocodazole and then raised to the restrictive temperature at the same time that expression of the Cdc6s was induced from the GAL1,10 promoter, for 30 min. At time 0, transcription and translation were prevented with glucose and cycloheximide, respectively. Samples were taken at the indicated time points and processed for immunoblotting. 9E10 was used for detecting the Cdc6-13myc proteins. (C) Rapid degradation in G1/S phase. Cdc6 from S.bayanus and S.castellii was compared with Cdc6 from S.cerevisiae for examination of the rapid degradation previously described as mode 2 [8] . Cells were synchronised in G1 with alpha factor and then released back into the cell cycle in medium containing galactose, so that the Cdc6 proteins were expressed these CDK-dependent mechanisms. To begin to address this, we asked whether we could effectively change the mechanism by which individual licensing factors are regulated in S.cerevisiae. CDKs do not directly regulate Cdt1 in budding yeast: Cdt1 levels are constant during the cell cycle and, although Cdt1 nuclear localization is regulated during the cell cycle, this regulation appears to occur passively via interactions with Mcm2-7 [19] . To confer CDK regulation onto Cdt1, we fused the N-terminal 214 amino acids from the CDK inhibitor Sic1 onto the N terminus of Cdt1 and expressed this as the sole copy of Cdt1 from the endogenous CDT1 (TAH11) promoter. This N-terminal domain of Sic1 lacks its CDK inhibitory activity, but contains multiple CDK phosphorylation sites that target it for SCF CDC4 -dependent proteolysis [20] . Figure 3A (and Figure S3B) shows that this fusion protein (Cdt1-d), like the wild-type Cdt1, is stable in alpha-factor-arrested cells. However, in contrast to wild-type Cdt1 (but similar to wild-type Sic1), it is unstable in nocodazole-arrested cells ( Figure 3A) . It is also degraded approximately 20-30 min after release from an alpha-factor block, similar to both Cdc6 and Coimmunoprecipitation experiments were performed on extracts of yeast expressing GAL1,10 Cdc6 proteins (see Experimental Procedures) for investigation of any interaction with Clb2. A sample was mock treated (-ab) as a control. After SDS-PAGE and western-blot transfer, the membrane was divided into three strips, according to MW range, for detection of Cdc6-13Myc, Clb2, and Cdc28. Control immunoprecipitations were performed on extracts made from the same strains incubated in glucose (no expression of GAL1,10 Cdc6 proteins). The supernatants after depletion (Sup) are shown on the left side of each panel, and the immunoprecipitiations (IP) are shown on the right side. (C) S.castellii Clb2 interaction with Cdc6. The ORF of Clb2 (with a 4xHA N-terminal tag) from S.castellii was expressed under the control of the GAL1,10 promoter in strains also containing either GAL1,10 Cdc6 from S.cerevisiae or GAL1,10 Cdc6 from S.castellii. Extracts were made from asynchronous cultures grown either in YPD, as a control, or YPGal. Each extract was split into three and treated for immunoprecipitation of Clb2 or Cdc6 or mock treated with no antibody. The supernatants and the immunoprecipitates were processed for immunoblotting. Sic1 ( Figure S3C ). Thus, budding yeast Cdt1 can be regulated by SCF-dependent, cell-cycle-regulated proteolysis without affecting viability.
Deregulation of ORC, Cdc6, and Mcm2-7 in G2/M-arrested cells induces substantial amounts of re-replication [17] . Figure 3B shows that replacement of wild-type Cdt1 with the Sic1-Cdt1 fusion protein suppressed this rereplication. Moreover, this fusion protein also suppressed much of the lethality associated with this re-replication ( Figure 3C ).
We then asked whether Sic1-Cdt1 could contribute to prevention of re-replication and promotion of viability over a longer period of time. Expression of Cdc6 lacking the NTD (Cdc6DNT) is lethal in cells expressing deregulated Orc2 and Orc6 [10] [18] . Figure 3D shows that this lethality was suppressed when wild-type Cdt1 was replaced with the Sic1-Cdt1 fusion protein. Thus, this heterologous fusion protein appears capable of participating effectively in preventing rereplication during sustained growth.
To provide an additional example of interchangeability, we replaced the NTD of Cdc6 with a cassette containing a bipartite nuclear localization sequence from Mcm2 and Mcm3 (NLS) and a nuclear export sequence (NES) from Mcm3. This cassette has been shown to confer cell-cycle-regulated nuclear localization on heterologous proteins [21] . The Mcm3 NES is regulated by CDK phosphorylation, so we also made a construct in which CDK regulation of this NES has been eliminated (nes), resulting in constitutive nuclear localization. Figure 3E shows that, in contrast to Cdc6DNT, Cdc6DNT fused to the wild-type NLS/ NES is viable in a background containing deregulated Orc2 and Orc6. This viability requires the CDK regulation of the NES. Thus, CDK-regulated nuclear exclusion can effectively be transferred from Mcm2-7 to Cdc6. Taken altogether, these experiments indicate that regulatory mechanisms can be effective in maintaining cell viability and preventing re-replication when swapped between pre-RC components.
Our experiments provide additional evidence that the regulation of licensing control has evolved relatively rapidly. Previous work showed that the cell-cycle regulation of Mcm2-7 nuclear localization, conserved in both sensu stricto and sensu lato Saccharomyces species, was acquired after divergence of the lineage leading to Candida albicans [22] . Our results indicate that the inhibition of Cdc6 by both Clb2 binding to the NTD and Cdc4 binding to the CTD was acquired even more recently in the lineage leading to the sensu stricto species. Although the binding of Clb2 to Cdc6 is specific for a relatively narrow group of budding yeasts, we note that the ability of mitotic cyclins to bind specifically to phosphorylated peptides, including the NTD of S.cerevisiae Cdc6, has been conserved in eukaryotic evolution between yeast and humans [10, 23] .
We previously suggested that redundancy provides a key driving force in the evolution of licensing control [2] . Because no single mechanism for inhibiting pre-RC components can be completely effective, multiple mechanisms are required for achievement of an efficient block to re-replication (Figure 4) . However, as the number of inhibitory mechanisms increases, the relative importance of any single mechanism decreases. During evolution, these regulatory mechanisms may be gained or lost, and an organism may ''sit'' at different positions along the curve in Figure 4 . We suggest that budding yeast is relatively far to the right on this curve: the single loss of Cdc6, Mcm2-7, or ORC regulation has little effect on growth, at least in the short term. Fission yeast, however, may have a less rich assortment of these mechanisms and appears to be more sensitive to the loss of any single mechanism: overexpression of Cdc6/18 is sufficient to induce extensive re-replication [24] . The appearance of geminin in metazoa provides an additional mechanism for preventing re-replication, which may have been important in supporting an increase in genome size.
In this paper, we have shown that re-replication can be effectively prevented when inhibitory mechanisms are swapped between pre-RC proteins. We propose that this feature contributes to the rapid evolution of licensing control. As we have previously discussed [2] , many pre-RC components have evolved additional functions in cells unrelated to DNA replication, and this may put some constraints on how any individual pre-RC component might be regulated in any particular organism.
Experimental Procedures
Strains and Constructs All strains used were derived from W303-1a (MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100), except for the strains used in the re-replication and transformation assay; these were derived from A364a (Mat a, ade1, ade2, ura1, his7, lys2, tyr1, gal1). For full description of strains and constructs, see Supplemental Data (available online).
Yeast Techniques
A yeast two-hybrid analysis was performed as described previously [6] , with the use of the yeast strain L40 and the bait and prey plasmids BTM116 and pACT. Transcriptional activation was measured on plates containing X-GAL and on minimal media plates supplemented for the required amino acids but lacking histidine. Media, cell-cycle experiments, and GAL1,10 promoter shut-off experiments have been described previously [6, 9] .
Re-replication assays and the transformation assay were performed as previously described [10] .
Samples for flow cytometry were collected and processed as described previously [25] . Analysis was performed with a Becton Dickinson FACScan.
Immunoprecipitation and Immunoblotting
Extracts from asynchronous cultures for use in immunoprecipitation were performed as previously described [10] . 9E11 was used for immunoprecipitating Cdc6 13xMyc proteins. sc-9071 (Insight Biotechnologies) was used for immunoprecipitating Clb2. 4xHA Clb2 from S.castellii was immunoprecipitated with the 12CA5 monoclonal antibody.
Protein extracts and immunoblotting were performed as described previously [8] . Monoclonal antibody 9H/8 was used for detecting Cdc6 and Cdc6DNT [6] . 9E10 was used for detecting 13xMyc-tagged Cdc6 proteins. sc-9071 (Insight Biotechnologies) was used for detecting Clb2. Anti-PSTAIR antibody was used for detecting Cdc28 (a gift from J. Gannon) at 1:10,000. JDI 70 polyclonal antibody was used for detecting Cdt1 and Cdt1-d. Sic1 was detected with JDI 53 polyclonal antibody. Protein A-HRP (GE Healthcare Biosciences), anti mouse IgG-HRP (Vector Labs), or anti goat IgG-HRP (Insight Biotechnologies) were used as secondary antibodies at 1:5000, as appropriate.
Supplemental Data
Supplemental data include Supplemental Experimental Procedures, three figures, and one table and can be found with this article online at http:// www.current-biology.com/supplemental/S0960-9822(09)00743-X.
